1887

Abstract

Sporotrichosis, caused by species of the complex, is the most prevalent subcutaneous mycosis in many areas of Latin America. Statins are a class of drugs widely used for lowering high sterol levels through their action on 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in the synthesis of sterol.

In this study, the antifungal activity of statins (simvastatin, atorvastatin, pravastatin) against planktonic cells and biofilms of complex species was evaluated, as well as the interaction of pravastatin with classical antifungals (amphotericin B, itraconazole, terbinafine).

Eighteen strains of species were used. The antifungal susceptibility assay was performed using the broth microdilution method. Mature biofilms were exposed to statins and metabolic activity was measured by the XTT reduction assay.

MICs of statins ranged from 8 to 512 μg ml and from 8 to 256 μg ml for filamentous and yeast forms, respectively. Regarding mature biofilms, MICs of 50 % inhibition (SMIC50) were 128 μg ml for simvastatin and atorvastatin and >2048 μg ml for pravastatin. MICs of 90 % inhibition (SMIC90) were 512 μg ml for simvastatin and >2048 μg ml for atorvastatin and pravastatin.

. These results highlight the antifungal and antibiofilm potential of statins against complex species.

Funding
This study was supported by the:
  • Raimunda Sâmia Nogueira Brilhante , CNPq , (Award 305024/2017-5)
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001195
2020-05-19
2020-06-02
Loading full text...

Full text loading...

/deliver/fulltext/jmm/10.1099/jmm.0.001195/jmm001195.html?itemId=/content/journal/jmm/10.1099/jmm.0.001195&mimeType=html&fmt=ahah

References

  1. Lopes-Bezerra LM, Mora-Montes HM, Bonifaz A. Sporothrix and Sporotrichosis. Current Progress in Medical Mycology New York: Springer; 2017 pp 309 331
    [Google Scholar]
  2. Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol 2015; 53: 3 14 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  3. Brilhante RSN, de Aguiar FRM, da Silva MLQ, de Oliveira JS, de Camargo ZP et al. Antifungal susceptibility of Sporothrix schenckii complex biofilms. Med Mycol 2018; 56: 297 306 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  4. Mitchell KF, Zarnowski R, Andes DR. Fungal super glue: the biofilm matrix and its composition, assembly, and functions. PLoS Pathog 2016; 12: e1005828 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  5. Brilhante RS, Pereira VS, Oliveira JS, Lopes RG, Rodrigues AM et al. Pentamidine inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents. Future Microbiol 2018; 13: 1129 1140 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  6. Brilhante RSN, Silva MLQda, Pereira VS, de Oliveira JS, Maciel JM et al. Potassium iodide and miltefosine inhibit biofilms of Sporothrix schenckii species complex in yeast and filamentous forms. Med Mycol 2019; 57: 764 772 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  7. Mahajan VK. Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract 2014; 2014: 1 13 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  8. Borba-Santos LP, Reis de Sá LF, Ramos JA, Rodrigues AM, de Camargo ZP et al. Tacrolimus Increases the Effectiveness of Itraconazole and Fluconazole against Sporothrix spp. Front Microbiol 2017; 8: 8 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  9. Nyilasi I, Kocsubé S, Krizsán K, Galgóczy L, Papp T et al. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. Sabouraudia 2013; 52: 140 148
    [Google Scholar]
  10. Brilhante RSN, Caetano EPde, Oliveira JS, Castelo-Branco DdeSCM, Souza ERY et al. Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species. Braz J Infect Dis 2015; 19: 459 465 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  11. Zhou Y, Yang H, Zhou X, Luo H, Tang F et al. Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway. Appl Microbiol Biotechnol 2018; 102: 5255 5264 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  12. CLSI Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi ; Approved Standard - Second Edition. CLSI document M38A2 Wayne, PA: Clinical and Laboratory Standards Institute; 2008
    [Google Scholar]
  13. CLSI Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - Third Edition. CLSI document M27A3 Wayne, PA: Clinical and Laboratory Standards; 2008
    [Google Scholar]
  14. Almeida-Paes R, Brito-Santos F, Figueiredo-Carvalho MHG, Machado ACS, Oliveira MME et al. Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis . Mem Inst Oswaldo Cruz 2017; 112: 376 381 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  15. Valentín A, Cantón E, Pemán J, Fernandez-Rivero ME, Tormo-Mas MA et al. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species. J Antimicrob Chemother 2016; 71: 3449 3452 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  16. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  17. Queiroz-Telles F, Buccheri R, Benard G. Sporotrichosis in immunocompromised hosts. J Fungi 2019; 5: 8 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  18. Rodrigues AM, de Hoog GS, de Camargo ZP. Sporothrix species causing outbreaks in animals and humans driven by Animal-Animal transmission. PLoS Pathog 2016; 12: e1005638 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  19. Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R et al. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. Med Mycol 2015; 53: 178 188 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  20. Qiao J, Kontoyiannis DP, Wan Z, Li R, Liu W. Antifungal activity of statins against Aspergillus species. Med Mycol 2007; 45: 589 593 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  21. Sanchotene KO, Brandolt TM, Klafke GB, Poester VR, Xavier MO. In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases. Med Mycol 2017 1 8
    [Google Scholar]
  22. Hoffman WF, Alberts AW, Anderson PS, Chen JS, Smith RL et al. 3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase inhibitors. 4. side chain ester derivatives of mevinolin. J Med Chem 1986; 29: 849 852 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  23. Graziano TS, Cuzzullin MC, Franco GC, Schwartz-Filho HO, de Andrade ED et al. Statins and antimicrobial effects: simvastatin as a potential drug against Staphylococcus aureus biofilm. PLoS One 10: e0128098 [CrossRef]
    [Google Scholar]
  24. Liu A, Wu Q, Guo J, Ares I, Rodríguez J-L et al. Statins: adverse reactions, oxidative stress and metabolic interactions. Pharmacol Ther 2019; 195: 54 84 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  25. Cabral ME, Figueroa LIC, Fariña JI. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae and Candida utilis-bioassays and ergosterol quantification. Rev Iberoam Micol 2013; 30: 31 38 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  26. Gyetvai A, Emri T, Takács K, Dergez T, Fekete A et al. Lovastatin possesses a fungistatic effect against Candida albicans, but does not trigger apoptosis in this opportunistic human pathogen. FEMS Yeast Res 2006; 6: 1140 1148 [CrossRef] [PubMed] [PubMed]
    [Google Scholar]
  27. Nyilasi I, Kocsubé S, Krizsán K, Galgóczy L, Papp T et al. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. Med Mycol 2013; 52: 140 148
    [Google Scholar]
  28. Parihar SP, Hartley M-A, Hurdayal R, Guler R, Brombacher F. Topical simvastatin as host-directed therapy against severity of cutaneous leishmaniasis in mice. Sci Rep 2016; 6: 1 10 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001195
Loading
/content/journal/jmm/10.1099/jmm.0.001195
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error